Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 2 | 100,0 % | 7 | 100,0 % | +192,02% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 7 | 100,0 % | +192,02% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 01/01/83 |
Anthony Marucci
FOU | Founder | 62 | 01/01/83 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 01/04/09 |
Diane Young
CTO | Chief Tech/Sci/R&D Officer | 68 | 08/07/19 |
Sarah Cavanaugh
ADM | Chief Administrative Officer | 49 | 01/08/12 |
Freddy Jimenez
LAW | General Counsel | 55 | 01/02/16 |
General Counsel | 67 | 03/10/17 | |
Richard Wright
PRN | Corporate Officer/Principal | 60 | 01/01/12 |
Corporate Officer/Principal | 52 | 01/01/09 | |
Ronald Pepin
PRN | Corporate Officer/Principal | 68 | 07/07/11 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 01/03/08 |
Cheryl Cohen
BRD | Director/Board Member | 58 | 16/06/22 |
Harry Penner
BRD | Director/Board Member | 78 | 01/01/97 |
James Marino
BRD | Director/Board Member | 74 | 08/03/17 |
Karen Shoos
CHM | Chairman | 70 | 01/05/01 |
Anthony Marucci
FOU | Founder | 62 | 01/01/83 |
Garry Neil
BRD | Director/Board Member | 70 | 16/06/22 |
Keith Brownlie
BRD | Director/Board Member | 71 | 15/06/17 |
Rita Jain
BRD | Director/Board Member | 62 | 16/02/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 65 910 548 | 65 721 561 ( 99,71 %) | 0 | 99,71 % |
Coordinate società
Celldex Therapeutics, Inc.
Perryville III Building 53 Frontage Road
08827, Hampton
+908 200 7500
http://www.celldex.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+25,83% | 46,56 Mrd | |
+45,38% | 41,67 Mrd | |
+0,69% | 41,16 Mrd | |
+30,52% | 32,4 Mrd | |
+22,30% | 28,18 Mrd | |
-6,35% | 28,1 Mrd | |
+49,25% | 14,52 Mrd | |
+49,18% | 13,74 Mrd | |
+3,45% | 12,17 Mrd |